Please login to the form below

Not currently logged in
Email:
Password:

fulranumab

This page shows the latest fulranumab news and features for those working in and with pharma, biotech and healthcare.

FDA fast-tracks Pfizer and Lilly's tanezumab

FDA fast-tracks Pfizer and Lilly's tanezumab

One competitor - Amgen - has been developing its own candidate called fulranumab, but former partners Johnson &Johnson and Takeda handed back rights to the project last year.

Latest news

More from news
Approximately 3 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics